Keller Rohrback Investigates Medtronic Pricing Practices & Potentially Defective Products
Keller Rohrback L.L.P., a leading consumer and antitrust law firm, is investigating various claims against medical technology development company, Medtronic, based on whistleblower allegations of illegal pricing practices and serious personal injuries or death as a result of defective Medtronic medical products used during surgery.
Medtronic is composed of several business units which develop and manufacture medical devices and therapies to treat a series of chronic diseases including heart failure, Parkinson’s disease, spinal disorders, and diabetes, among others.
In recent years, several whistleblower complaints have been filed based on allegations by former medical device salespersons and employees that Medtronic engaged in various illegal schemes to target physicians and staff with kickbacks; manipulating studies to drive up share prices; as well as improper Medicare billing practices.
In addition, recalls of Medtronic devices have led to cases being filed for serious personal injury or death. Devices currently being investigated include: Medtronic SynchroMed II infusion pump, Infuse Bone Grafts, Verte-Stack (vertebral surgical implants), and Medtronic Insulin Pumps.
If you have information or have suffered an injury as a result of a Medtronic device, please call attorneys Michael Woerner, or Mark Samson at (800) 776-6044 or via email at email@example.com to discuss our investigation and your potential legal claims.
With offices in Seattle, Phoenix, New York, Ronan, Oakland, and Santa Barbara, Keller Rohrback L.L.P. serves as lead and co-lead counsel in class actions throughout the country. Our Complex Litigation Group is proud to offer its expertise to clients nationwide, and our trial lawyers have obtained judgments and settlements on behalf of clients in excess of seven billion dollars.